Primary Care/Hospitalist
RSSArticles
-
An Update on the Emergency Department Management of Asthma Part I: Pathophysiology and Management Strategies
In the United States during 2002, asthma accounted for 12.7 million physician visits; 1.9 million emergency department (ED) visits; 484,000 hospitalizations; and 4,261 deaths. The prevalence of asthma in our society has led it to be the eleventh most common diagnosis in the ED. The direct and indirect costs of the disease are estimated to exceed $14 billion annually in the United States alone. -
Full February 6, 2006 issue in PDF
-
Clinical Briefs By Louis Kuritzky, MD
Febuxostat Compared with Allopurinol in Patients with Hyperuricemia and Gout; Prognostic Value of Serial B-Type Natriuretic Peptide Testing During Follow-up of Patients with Unstable Coronary Artery Disease; Dietary Fiber Intake and Risk of Colorectal Cancer -
Gastric Acid-Suppressive Agents and Risk of Community-Acquired C. difficile
Acid suppression, particularly with proton pump inhibitors (PPIs) is correlated with an increased risk of community-acquired Clostridium difficile colitis. -
Metabolic Syndrome: A Warning of Cardiovascular Disease and Type 2 Diabetes Mellitus?
Metabolic syndrome is common and is associated with an increased risk for CVD and T2DM in both sexes. -
A Novel Treatment for Diabetic Foot Ulcers
Tretinoin solution helps heal diabetic foot ulcers. -
Full January 29, 2006 Issue in PDF
-
Pharmacology Update: Levalbuterol Tartrate Inhalation Aerosol (Xopenex HFA)
The FDA has approved a cfc-free levalbuterol aerosol inhaler for the treatment of asthma. Levalbuterol is the active isomer of albuterol and has been available in a nebulized solution for many years. This new formulation is marketed by Sepracor as Xopenex HFA. -
Osteoporosis Medications: Are your Patients Really Taking Them?
A 6-year retrospective study shows that 45% of Medicare patients with state-funded drug benefits who initiate a medication for osteoporosis do not continue to take it as prescribed one year later and 52% are no longer compliant 5-years later. -
Full February 2006 Issue in PDF